nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—UGT1A3—Ezetimibe—atherosclerosis	0.105	0.123	CbGbCtD
Flunitrazepam—UGT1A3—Simvastatin—atherosclerosis	0.0974	0.114	CbGbCtD
Flunitrazepam—UGT1A3—Lovastatin—atherosclerosis	0.0953	0.112	CbGbCtD
Flunitrazepam—UGT2B7—Ezetimibe—atherosclerosis	0.0758	0.0886	CbGbCtD
Flunitrazepam—UGT2B7—Simvastatin—atherosclerosis	0.0704	0.0824	CbGbCtD
Flunitrazepam—UGT2B7—Lovastatin—atherosclerosis	0.0689	0.0806	CbGbCtD
Flunitrazepam—UGT1A1—Ezetimibe—atherosclerosis	0.0655	0.0766	CbGbCtD
Flunitrazepam—UGT1A1—Simvastatin—atherosclerosis	0.0609	0.0712	CbGbCtD
Flunitrazepam—UGT1A1—Lovastatin—atherosclerosis	0.0596	0.0697	CbGbCtD
Flunitrazepam—CYP2B6—Simvastatin—atherosclerosis	0.0236	0.0275	CbGbCtD
Flunitrazepam—CYP2C19—Rosuvastatin—atherosclerosis	0.0161	0.0188	CbGbCtD
Flunitrazepam—CYP2C19—Simvastatin—atherosclerosis	0.015	0.0175	CbGbCtD
Flunitrazepam—CYP2C19—Lovastatin—atherosclerosis	0.0146	0.0171	CbGbCtD
Flunitrazepam—CYP2C9—Rosuvastatin—atherosclerosis	0.0134	0.0157	CbGbCtD
Flunitrazepam—CYP2C9—Simvastatin—atherosclerosis	0.0124	0.0145	CbGbCtD
Flunitrazepam—CYP2C9—Lovastatin—atherosclerosis	0.0122	0.0142	CbGbCtD
Flunitrazepam—CYP2C9—Pravastatin—atherosclerosis	0.0122	0.0142	CbGbCtD
Flunitrazepam—CYP3A4—Ezetimibe—atherosclerosis	0.00778	0.0091	CbGbCtD
Flunitrazepam—CYP3A4—Rosuvastatin—atherosclerosis	0.00778	0.0091	CbGbCtD
Flunitrazepam—CYP3A4—Simvastatin—atherosclerosis	0.00723	0.00846	CbGbCtD
Flunitrazepam—CYP3A4—Lovastatin—atherosclerosis	0.00708	0.00828	CbGbCtD
Flunitrazepam—CYP3A4—Pravastatin—atherosclerosis	0.00708	0.00828	CbGbCtD
Flunitrazepam—Sleep disturbance—Simvastatin—atherosclerosis	0.00327	0.0422	CcSEcCtD
Flunitrazepam—Sleep disturbance—Pravastatin—atherosclerosis	0.00296	0.0381	CcSEcCtD
Flunitrazepam—Nightmare—Rosuvastatin—atherosclerosis	0.00223	0.0288	CcSEcCtD
Flunitrazepam—Sleep disorder—Rosuvastatin—atherosclerosis	0.00194	0.025	CcSEcCtD
Flunitrazepam—Amnesia—Rosuvastatin—atherosclerosis	0.00179	0.023	CcSEcCtD
Flunitrazepam—Nightmare—Simvastatin—atherosclerosis	0.00177	0.0228	CcSEcCtD
Flunitrazepam—Nightmare—Pravastatin—atherosclerosis	0.0016	0.0206	CcSEcCtD
Flunitrazepam—Sleep disorder—Simvastatin—atherosclerosis	0.00154	0.0198	CcSEcCtD
Flunitrazepam—Amnesia—Lovastatin—atherosclerosis	0.00151	0.0195	CcSEcCtD
Flunitrazepam—Amnesia—Ezetimibe—atherosclerosis	0.00149	0.0192	CcSEcCtD
Flunitrazepam—Muscular weakness—Rosuvastatin—atherosclerosis	0.00148	0.0191	CcSEcCtD
Flunitrazepam—Amnesia—Simvastatin—atherosclerosis	0.00142	0.0183	CcSEcCtD
Flunitrazepam—Sleep disorder—Pravastatin—atherosclerosis	0.00139	0.0179	CcSEcCtD
Flunitrazepam—Amnesia—Pravastatin—atherosclerosis	0.00128	0.0165	CcSEcCtD
Flunitrazepam—Muscular weakness—Ezetimibe—atherosclerosis	0.00123	0.0159	CcSEcCtD
Flunitrazepam—Diplopia—Pravastatin—atherosclerosis	0.0012	0.0155	CcSEcCtD
Flunitrazepam—Muscular weakness—Simvastatin—atherosclerosis	0.00117	0.0151	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Niacin—atherosclerosis	0.00112	0.0144	CcSEcCtD
Flunitrazepam—Muscular weakness—Niacin—atherosclerosis	0.00108	0.0139	CcSEcCtD
Flunitrazepam—Muscular weakness—Pravastatin—atherosclerosis	0.00106	0.0137	CcSEcCtD
Flunitrazepam—Angioedema—Rosuvastatin—atherosclerosis	0.000924	0.0119	CcSEcCtD
Flunitrazepam—Sweating—Niacin—atherosclerosis	0.000903	0.0116	CcSEcCtD
Flunitrazepam—Confusional state—Rosuvastatin—atherosclerosis	0.000832	0.0107	CcSEcCtD
Flunitrazepam—Tremor—Lovastatin—atherosclerosis	0.000803	0.0104	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Lovastatin—atherosclerosis	0.000795	0.0103	CcSEcCtD
Flunitrazepam—Angioedema—Lovastatin—atherosclerosis	0.000783	0.0101	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00078	0.0101	CcSEcCtD
Flunitrazepam—Malaise—Lovastatin—atherosclerosis	0.000773	0.00997	CcSEcCtD
Flunitrazepam—Angioedema—Ezetimibe—atherosclerosis	0.000768	0.0099	CcSEcCtD
Flunitrazepam—Malaise—Ezetimibe—atherosclerosis	0.000758	0.00977	CcSEcCtD
Flunitrazepam—Tremor—Simvastatin—atherosclerosis	0.000751	0.00968	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Simvastatin—atherosclerosis	0.000744	0.00959	CcSEcCtD
Flunitrazepam—Angioedema—Simvastatin—atherosclerosis	0.000732	0.00944	CcSEcCtD
Flunitrazepam—Anxiety—Lovastatin—atherosclerosis	0.000727	0.00938	CcSEcCtD
Flunitrazepam—Malaise—Simvastatin—atherosclerosis	0.000723	0.00932	CcSEcCtD
Flunitrazepam—Discomfort—Lovastatin—atherosclerosis	0.000721	0.0093	CcSEcCtD
Flunitrazepam—Dry mouth—Lovastatin—atherosclerosis	0.000713	0.0092	CcSEcCtD
Flunitrazepam—Discomfort—Ezetimibe—atherosclerosis	0.000707	0.00912	CcSEcCtD
Flunitrazepam—Confusional state—Lovastatin—atherosclerosis	0.000705	0.00909	CcSEcCtD
Flunitrazepam—Dry mouth—Ezetimibe—atherosclerosis	0.0007	0.00902	CcSEcCtD
Flunitrazepam—Confusional state—Ezetimibe—atherosclerosis	0.000692	0.00892	CcSEcCtD
Flunitrazepam—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00068	0.00877	CcSEcCtD
Flunitrazepam—Anxiety—Simvastatin—atherosclerosis	0.00068	0.00877	CcSEcCtD
Flunitrazepam—Tremor—Pravastatin—atherosclerosis	0.000679	0.00876	CcSEcCtD
Flunitrazepam—Discomfort—Simvastatin—atherosclerosis	0.000674	0.00869	CcSEcCtD
Flunitrazepam—Angioedema—Niacin—atherosclerosis	0.000672	0.00867	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Pravastatin—atherosclerosis	0.000672	0.00867	CcSEcCtD
Flunitrazepam—Angioedema—Pravastatin—atherosclerosis	0.000662	0.00854	CcSEcCtD
Flunitrazepam—Confusional state—Simvastatin—atherosclerosis	0.00066	0.00851	CcSEcCtD
Flunitrazepam—Malaise—Pravastatin—atherosclerosis	0.000653	0.00843	CcSEcCtD
Flunitrazepam—Anxiety—Pravastatin—atherosclerosis	0.000615	0.00793	CcSEcCtD
Flunitrazepam—Dry mouth—Niacin—atherosclerosis	0.000613	0.0079	CcSEcCtD
Flunitrazepam—Discomfort—Pravastatin—atherosclerosis	0.00061	0.00786	CcSEcCtD
Flunitrazepam—Fatigue—Lovastatin—atherosclerosis	0.000603	0.00778	CcSEcCtD
Flunitrazepam—Confusional state—Pravastatin—atherosclerosis	0.000596	0.00769	CcSEcCtD
Flunitrazepam—Asthenia—Rosuvastatin—atherosclerosis	0.000592	0.00764	CcSEcCtD
Flunitrazepam—Fatigue—Ezetimibe—atherosclerosis	0.000591	0.00763	CcSEcCtD
Flunitrazepam—Tachycardia—Niacin—atherosclerosis	0.000586	0.00756	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Niacin—atherosclerosis	0.000581	0.00749	CcSEcCtD
Flunitrazepam—Feeling abnormal—Lovastatin—atherosclerosis	0.000576	0.00743	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Pravastatin—atherosclerosis	0.000572	0.00737	CcSEcCtD
Flunitrazepam—Feeling abnormal—Ezetimibe—atherosclerosis	0.000565	0.00729	CcSEcCtD
Flunitrazepam—Fatigue—Simvastatin—atherosclerosis	0.000564	0.00727	CcSEcCtD
Flunitrazepam—Hypotension—Niacin—atherosclerosis	0.000561	0.00724	CcSEcCtD
Flunitrazepam—Dizziness—Rosuvastatin—atherosclerosis	0.000546	0.00704	CcSEcCtD
Flunitrazepam—TSPO—hindlimb—atherosclerosis	0.000544	0.167	CbGeAlD
Flunitrazepam—Feeling abnormal—Simvastatin—atherosclerosis	0.000539	0.00695	CcSEcCtD
Flunitrazepam—Somnolence—Niacin—atherosclerosis	0.000534	0.00689	CcSEcCtD
Flunitrazepam—Rash—Rosuvastatin—atherosclerosis	0.00052	0.00671	CcSEcCtD
Flunitrazepam—Dermatitis—Rosuvastatin—atherosclerosis	0.00052	0.0067	CcSEcCtD
Flunitrazepam—Headache—Rosuvastatin—atherosclerosis	0.000517	0.00667	CcSEcCtD
Flunitrazepam—Fatigue—Pravastatin—atherosclerosis	0.00051	0.00658	CcSEcCtD
Flunitrazepam—Asthenia—Lovastatin—atherosclerosis	0.000502	0.00647	CcSEcCtD
Flunitrazepam—Asthenia—Ezetimibe—atherosclerosis	0.000492	0.00635	CcSEcCtD
Flunitrazepam—Feeling abnormal—Pravastatin—atherosclerosis	0.000487	0.00628	CcSEcCtD
Flunitrazepam—Asthenia—Simvastatin—atherosclerosis	0.000469	0.00605	CcSEcCtD
Flunitrazepam—TSPO—appendage—atherosclerosis	0.000467	0.143	CbGeAlD
Flunitrazepam—Dizziness—Lovastatin—atherosclerosis	0.000462	0.00596	CcSEcCtD
Flunitrazepam—Dizziness—Ezetimibe—atherosclerosis	0.000454	0.00585	CcSEcCtD
Flunitrazepam—Rash—Lovastatin—atherosclerosis	0.000441	0.00569	CcSEcCtD
Flunitrazepam—Dermatitis—Lovastatin—atherosclerosis	0.000441	0.00568	CcSEcCtD
Flunitrazepam—Headache—Lovastatin—atherosclerosis	0.000438	0.00565	CcSEcCtD
Flunitrazepam—Dizziness—Simvastatin—atherosclerosis	0.000433	0.00558	CcSEcCtD
Flunitrazepam—Rash—Ezetimibe—atherosclerosis	0.000432	0.00558	CcSEcCtD
Flunitrazepam—Dermatitis—Ezetimibe—atherosclerosis	0.000432	0.00557	CcSEcCtD
Flunitrazepam—Asthenia—Niacin—atherosclerosis	0.000431	0.00556	CcSEcCtD
Flunitrazepam—Headache—Ezetimibe—atherosclerosis	0.00043	0.00554	CcSEcCtD
Flunitrazepam—Asthenia—Pravastatin—atherosclerosis	0.000424	0.00547	CcSEcCtD
Flunitrazepam—Rash—Simvastatin—atherosclerosis	0.000412	0.00532	CcSEcCtD
Flunitrazepam—Dermatitis—Simvastatin—atherosclerosis	0.000412	0.00531	CcSEcCtD
Flunitrazepam—Headache—Simvastatin—atherosclerosis	0.00041	0.00528	CcSEcCtD
Flunitrazepam—Dizziness—Niacin—atherosclerosis	0.000397	0.00512	CcSEcCtD
Flunitrazepam—Dizziness—Pravastatin—atherosclerosis	0.000391	0.00504	CcSEcCtD
Flunitrazepam—Rash—Niacin—atherosclerosis	0.000379	0.00488	CcSEcCtD
Flunitrazepam—Dermatitis—Niacin—atherosclerosis	0.000378	0.00488	CcSEcCtD
Flunitrazepam—Headache—Niacin—atherosclerosis	0.000376	0.00485	CcSEcCtD
Flunitrazepam—Rash—Pravastatin—atherosclerosis	0.000373	0.00481	CcSEcCtD
Flunitrazepam—Dermatitis—Pravastatin—atherosclerosis	0.000373	0.0048	CcSEcCtD
Flunitrazepam—Headache—Pravastatin—atherosclerosis	0.00037	0.00478	CcSEcCtD
Flunitrazepam—TSPO—artery—atherosclerosis	0.000333	0.102	CbGeAlD
Flunitrazepam—TSPO—blood vessel—atherosclerosis	0.00026	0.0796	CbGeAlD
Flunitrazepam—UGT1A3—liver—atherosclerosis	0.000213	0.0652	CbGeAlD
Flunitrazepam—TSPO—connective tissue—atherosclerosis	0.000133	0.0408	CbGeAlD
Flunitrazepam—CYP2A6—adipose tissue—atherosclerosis	0.000125	0.0383	CbGeAlD
Flunitrazepam—UGT2B7—liver—atherosclerosis	0.000122	0.0375	CbGeAlD
Flunitrazepam—TSPO—cardiovascular system—atherosclerosis	0.000116	0.0355	CbGeAlD
Flunitrazepam—GABRA2—adipose tissue—atherosclerosis	0.00011	0.0338	CbGeAlD
Flunitrazepam—UGT1A1—liver—atherosclerosis	0.000104	0.0319	CbGeAlD
Flunitrazepam—TSPO—adipose tissue—atherosclerosis	0.000102	0.0313	CbGeAlD
Flunitrazepam—CYP2A6—liver—atherosclerosis	8.76e-05	0.0268	CbGeAlD
Flunitrazepam—TSPO—liver—atherosclerosis	7.16e-05	0.022	CbGeAlD
Flunitrazepam—CYP2B6—cardiovascular system—atherosclerosis	7.13e-05	0.0219	CbGeAlD
Flunitrazepam—CYP2C9—cardiovascular system—atherosclerosis	7.06e-05	0.0216	CbGeAlD
Flunitrazepam—CYP2E1—cardiovascular system—atherosclerosis	6.69e-05	0.0205	CbGeAlD
Flunitrazepam—CYP2C19—liver—atherosclerosis	5.63e-05	0.0173	CbGeAlD
Flunitrazepam—CYP1A2—liver—atherosclerosis	4.6e-05	0.0141	CbGeAlD
Flunitrazepam—CYP2B6—liver—atherosclerosis	4.41e-05	0.0135	CbGeAlD
Flunitrazepam—CYP2C9—liver—atherosclerosis	4.37e-05	0.0134	CbGeAlD
Flunitrazepam—CYP2E1—liver—atherosclerosis	4.14e-05	0.0127	CbGeAlD
Flunitrazepam—CYP3A4—liver—atherosclerosis	3.33e-05	0.0102	CbGeAlD
Flunitrazepam—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.02e-05	0.00016	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.02e-05	0.000159	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—LPA—atherosclerosis	1.02e-05	0.000159	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PPARA—atherosclerosis	1.02e-05	0.000159	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—INS—atherosclerosis	1.02e-05	0.000159	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.01e-05	0.000158	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.01e-05	0.000157	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—HMGCR—atherosclerosis	1e-05	0.000157	CbGpPWpGaD
Flunitrazepam—Acenocoumarol—ALB—atherosclerosis	9.98e-06	0.429	CrCbGaD
Flunitrazepam—CYP2C19—Metabolism—ALOX5—atherosclerosis	9.95e-06	0.000155	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	9.92e-06	0.000155	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—BGN—atherosclerosis	9.86e-06	0.000154	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AGT—atherosclerosis	9.85e-06	0.000154	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.79e-06	0.000153	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOA5—atherosclerosis	9.76e-06	0.000152	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—HMOX1—atherosclerosis	9.71e-06	0.000152	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—APOE—atherosclerosis	9.66e-06	0.000151	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP27A1—atherosclerosis	9.62e-06	0.00015	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PTGS2—atherosclerosis	9.58e-06	0.00015	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CAV1—atherosclerosis	9.57e-06	0.000149	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—APOA1—atherosclerosis	9.54e-06	0.000149	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.48e-06	0.000148	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	9.47e-06	0.000148	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	9.4e-06	0.000147	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ALB—atherosclerosis	9.31e-06	0.000145	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—APOB—atherosclerosis	9.3e-06	0.000145	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.29e-06	0.000145	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	9.24e-06	0.000144	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.21e-06	0.000144	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.2e-06	0.000144	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.18e-06	0.000143	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ABCA1—atherosclerosis	9.13e-06	0.000143	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALOX15—atherosclerosis	9.12e-06	0.000142	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	9.12e-06	0.000142	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	9.12e-06	0.000142	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOA2—atherosclerosis	9.12e-06	0.000142	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALOX5—atherosclerosis	9.08e-06	0.000142	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GSTM1—atherosclerosis	9.05e-06	0.000141	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ABCG5—atherosclerosis	9.01e-06	0.000141	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	9e-06	0.000141	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ABCA1—atherosclerosis	8.94e-06	0.00014	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NAMPT—atherosclerosis	8.93e-06	0.000139	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—NOS3—atherosclerosis	8.9e-06	0.000139	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—LPL—atherosclerosis	8.88e-06	0.000139	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.88e-06	0.000139	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—LIPC—atherosclerosis	8.87e-06	0.000139	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCG1—atherosclerosis	8.86e-06	0.000138	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOC3—atherosclerosis	8.82e-06	0.000138	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—LDLR—atherosclerosis	8.76e-06	0.000137	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CG—atherosclerosis	8.71e-06	0.000136	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—LPA—atherosclerosis	8.7e-06	0.000136	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GPX1—atherosclerosis	8.66e-06	0.000135	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CETP—atherosclerosis	8.56e-06	0.000134	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CD36—atherosclerosis	8.44e-06	0.000132	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—BGN—atherosclerosis	8.43e-06	0.000132	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PPARG—atherosclerosis	8.41e-06	0.000131	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.39e-06	0.000131	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.37e-06	0.000131	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOA5—atherosclerosis	8.34e-06	0.00013	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—FABP4—atherosclerosis	8.33e-06	0.00013	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LCAT—atherosclerosis	8.33e-06	0.00013	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—INS—atherosclerosis	8.25e-06	0.000129	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SCARB1—atherosclerosis	8.2e-06	0.000128	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOA4—atherosclerosis	8.18e-06	0.000128	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTGS2—atherosclerosis	8.14e-06	0.000127	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.14e-06	0.000127	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.1e-06	0.000127	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.09e-06	0.000126	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—LIPC—atherosclerosis	8.09e-06	0.000126	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOC3—atherosclerosis	8.04e-06	0.000126	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.03e-06	0.000125	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	8.03e-06	0.000125	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—MTHFR—atherosclerosis	7.99e-06	0.000125	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—LDLR—atherosclerosis	7.99e-06	0.000125	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.98e-06	0.000125	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.94e-06	0.000124	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.87e-06	0.000123	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.85e-06	0.000123	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PPARA—atherosclerosis	7.84e-06	0.000122	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—HMOX1—atherosclerosis	7.83e-06	0.000122	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CETP—atherosclerosis	7.8e-06	0.000122	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALOX5—atherosclerosis	7.76e-06	0.000121	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—HMGCR—atherosclerosis	7.74e-06	0.000121	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—HMOX1—atherosclerosis	7.67e-06	0.00012	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AGT—atherosclerosis	7.6e-06	0.000119	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ALB—atherosclerosis	7.56e-06	0.000118	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APOB—atherosclerosis	7.5e-06	0.000117	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.47e-06	0.000117	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—APOE—atherosclerosis	7.44e-06	0.000116	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.43e-06	0.000116	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CAV1—atherosclerosis	7.37e-06	0.000115	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—APOA1—atherosclerosis	7.36e-06	0.000115	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APOB—atherosclerosis	7.35e-06	0.000115	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTM1—atherosclerosis	7.3e-06	0.000114	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.28e-06	0.000114	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NOS3—atherosclerosis	7.23e-06	0.000113	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.17e-06	0.000112	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—LPL—atherosclerosis	7.16e-06	0.000112	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTM1—atherosclerosis	7.15e-06	0.000112	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.06e-06	0.00011	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.04e-06	0.00011	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.04e-06	0.00011	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOA2—atherosclerosis	7.04e-06	0.00011	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.04e-06	0.00011	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—LPL—atherosclerosis	7.02e-06	0.00011	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GPX1—atherosclerosis	6.99e-06	0.000109	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.98e-06	0.000109	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NAMPT—atherosclerosis	6.96e-06	0.000109	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.95e-06	0.000109	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.92e-06	0.000108	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—LIPC—atherosclerosis	6.91e-06	0.000108	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ABCA1—atherosclerosis	6.9e-06	0.000108	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOC3—atherosclerosis	6.87e-06	0.000107	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GPX1—atherosclerosis	6.85e-06	0.000107	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—LDLR—atherosclerosis	6.83e-06	0.000107	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CD36—atherosclerosis	6.81e-06	0.000106	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CG—atherosclerosis	6.72e-06	0.000105	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LPA—atherosclerosis	6.72e-06	0.000105	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CETP—atherosclerosis	6.67e-06	0.000104	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CD36—atherosclerosis	6.67e-06	0.000104	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—atherosclerosis	6.62e-06	0.000103	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—BGN—atherosclerosis	6.5e-06	0.000102	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PPARG—atherosclerosis	6.48e-06	0.000101	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—MTHFR—atherosclerosis	6.45e-06	0.000101	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOA5—atherosclerosis	6.44e-06	0.000101	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SCARB1—atherosclerosis	6.39e-06	9.97e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.37e-06	9.94e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—INS—atherosclerosis	6.36e-06	9.93e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPARA—atherosclerosis	6.33e-06	9.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—MTHFR—atherosclerosis	6.32e-06	9.87e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.29e-06	9.82e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.22e-06	9.71e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPARA—atherosclerosis	6.2e-06	9.68e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.2e-06	9.68e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AGT—atherosclerosis	6.13e-06	9.57e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—HMGCR—atherosclerosis	6.03e-06	9.42e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APOE—atherosclerosis	6.01e-06	9.38e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AGT—atherosclerosis	6e-06	9.37e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.99e-06	9.35e-05	CbGpPWpGaD
Flunitrazepam—Ketazolam—ALB—atherosclerosis	5.98e-06	0.257	CrCbGaD
Flunitrazepam—CYP2B6—Metabolism—CAV1—atherosclerosis	5.95e-06	9.29e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APOA1—atherosclerosis	5.94e-06	9.27e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—HMOX1—atherosclerosis	5.92e-06	9.24e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APOE—atherosclerosis	5.88e-06	9.18e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ALB—atherosclerosis	5.83e-06	9.1e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CAV1—atherosclerosis	5.83e-06	9.1e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APOA1—atherosclerosis	5.81e-06	9.08e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOB—atherosclerosis	5.67e-06	8.85e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—NOS3—atherosclerosis	5.58e-06	8.71e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTM1—atherosclerosis	5.52e-06	8.61e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.44e-06	8.5e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CG—atherosclerosis	5.42e-06	8.46e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—LPL—atherosclerosis	5.41e-06	8.45e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.4e-06	8.43e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ABCA1—atherosclerosis	5.38e-06	8.39e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.37e-06	8.38e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LIPC—atherosclerosis	5.33e-06	8.33e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CG—atherosclerosis	5.31e-06	8.29e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOC3—atherosclerosis	5.3e-06	8.28e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GPX1—atherosclerosis	5.28e-06	8.25e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LDLR—atherosclerosis	5.27e-06	8.23e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPARG—atherosclerosis	5.23e-06	8.17e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOB—atherosclerosis	5.17e-06	8.07e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CETP—atherosclerosis	5.15e-06	8.04e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CD36—atherosclerosis	5.14e-06	8.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—INS—atherosclerosis	5.13e-06	8.01e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPARG—atherosclerosis	5.12e-06	8e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—atherosclerosis	5.1e-06	7.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.03e-06	7.85e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—INS—atherosclerosis	5.02e-06	7.85e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—LPL—atherosclerosis	4.94e-06	7.71e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.93e-06	7.7e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—MTHFR—atherosclerosis	4.87e-06	7.61e-05	CbGpPWpGaD
Flunitrazepam—Clonazepam—ALB—atherosclerosis	4.82e-06	0.207	CrCbGaD
Flunitrazepam—CYP2C9—Metabolism—GPX1—atherosclerosis	4.82e-06	7.52e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKT1—atherosclerosis	4.81e-06	7.51e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPARA—atherosclerosis	4.78e-06	7.47e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ALB—atherosclerosis	4.7e-06	7.34e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CD36—atherosclerosis	4.69e-06	7.32e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.65e-06	7.27e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AGT—atherosclerosis	4.63e-06	7.23e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.61e-06	7.2e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ALB—atherosclerosis	4.61e-06	7.19e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOE—atherosclerosis	4.54e-06	7.09e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NOS3—atherosclerosis	4.5e-06	7.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CAV1—atherosclerosis	4.5e-06	7.02e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOA1—atherosclerosis	4.49e-06	7.01e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.44e-06	6.94e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOB—atherosclerosis	4.42e-06	6.9e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NOS3—atherosclerosis	4.41e-06	6.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPARA—atherosclerosis	4.36e-06	6.81e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.3e-06	6.71e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AGT—atherosclerosis	4.22e-06	6.59e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—LPL—atherosclerosis	4.22e-06	6.59e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.15e-06	6.48e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOE—atherosclerosis	4.14e-06	6.46e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GPX1—atherosclerosis	4.12e-06	6.43e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—atherosclerosis	4.11e-06	6.43e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CAV1—atherosclerosis	4.1e-06	6.4e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.1e-06	6.4e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKT1—atherosclerosis	4.09e-06	6.39e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOA1—atherosclerosis	4.09e-06	6.39e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—atherosclerosis	4.03e-06	6.29e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CD36—atherosclerosis	4.01e-06	6.26e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPARG—atherosclerosis	3.95e-06	6.17e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—INS—atherosclerosis	3.88e-06	6.05e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.8e-06	5.93e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.73e-06	5.83e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPARA—atherosclerosis	3.73e-06	5.82e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AGT—atherosclerosis	3.61e-06	5.64e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPARG—atherosclerosis	3.6e-06	5.63e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.56e-06	5.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ALB—atherosclerosis	3.55e-06	5.55e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOE—atherosclerosis	3.54e-06	5.52e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—INS—atherosclerosis	3.53e-06	5.52e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CAV1—atherosclerosis	3.5e-06	5.47e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOA1—atherosclerosis	3.5e-06	5.46e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOB—atherosclerosis	3.41e-06	5.32e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NOS3—atherosclerosis	3.4e-06	5.31e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKT1—atherosclerosis	3.33e-06	5.19e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.32e-06	5.18e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LPL—atherosclerosis	3.26e-06	5.08e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALB—atherosclerosis	3.24e-06	5.06e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.19e-06	4.98e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GPX1—atherosclerosis	3.18e-06	4.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.11e-06	4.86e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NOS3—atherosclerosis	3.1e-06	4.84e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CD36—atherosclerosis	3.09e-06	4.83e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPARG—atherosclerosis	3.08e-06	4.81e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—INS—atherosclerosis	3.02e-06	4.72e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.93e-06	4.58e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPARA—atherosclerosis	2.88e-06	4.49e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.84e-06	4.43e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AGT—atherosclerosis	2.79e-06	4.35e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALB—atherosclerosis	2.77e-06	4.32e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOE—atherosclerosis	2.73e-06	4.26e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CAV1—atherosclerosis	2.7e-06	4.22e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOA1—atherosclerosis	2.7e-06	4.21e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NOS3—atherosclerosis	2.65e-06	4.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKT1—atherosclerosis	2.56e-06	4e-05	CbGpPWpGaD
Flunitrazepam—Diazepam—ALB—atherosclerosis	2.47e-06	0.106	CrCbGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.46e-06	3.85e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.42e-06	3.78e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPARG—atherosclerosis	2.38e-06	3.71e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—INS—atherosclerosis	2.33e-06	3.64e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALB—atherosclerosis	2.14e-06	3.34e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKT1—atherosclerosis	2.07e-06	3.23e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NOS3—atherosclerosis	2.04e-06	3.19e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKT1—atherosclerosis	2.03e-06	3.16e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.87e-06	2.92e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKT1—atherosclerosis	1.56e-06	2.44e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKT1—atherosclerosis	1.42e-06	2.23e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKT1—atherosclerosis	1.22e-06	1.9e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKT1—atherosclerosis	9.4e-07	1.47e-05	CbGpPWpGaD
